Jacob Johnson learned that he was a carrier for the BRCA2 gene in 2013 after testing was recommended due to a strong history of breast cancer among relatives — including his mother, several aunts, a ...
NASHVILLE, Tenn. (WSMV) - A bill moving through the Tennessee legislature would require insurance companies to cover biomarker testing, a screening that can detect early signs of disease, including ...
The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...
The median OS was 28 months with abiraterone-prednisone, 37 months with olaparib alone, and 68 months with abiraterone-prednisone-olaparib. In patients with metastatic castration-resistant prostate ...
Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of Texas MD ...
Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...
GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
Chennai: One in four Indian breast cancer patients carries inherited genetic variants that raise cancer risk beyond the commonly tested BRCA1 and BRCA2 genes — which can boost lifetime risk up to 70% ...
One in four Breast Cancer patients in India carry inherited genetic risk variants linked to cancer risk, according to a study conducted by the IIT-Madras and Karikinos Healthcare.
In this study, researchers aimed to evaluate the efficacy of targeting androgen receptor in mCRPC with a combination of abiraterone, prednisone, and olaparib. The median OS was 28 months with ...
In this study, researchers aimed to evaluate the efficacy of targeting androgen receptor in mCRPC with a combination of abiraterone, prednisone, and olaparib. Renal and Urology News, a trusted source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results